http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104592302-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_daab2839a9b32c81bdbf1e7ffa183ea3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-72
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N24-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-72
filingDate 2008-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2093dbc0a43a11a0c2a11205c41beb61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f46d6c2fa1dc3e44ed7edf5103674a36
publicationDate 2015-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104592302-A
titleOfInvention Compounds and methods for treating cancer
abstract The present invention provides methods for synthesizing organic arsenic compounds. Many of these compounds possess potent in vitro cytotoxic activity against a variety of human tumor cell lines of solid and hematological origin, as well as against malignant blood cells of leukemia patients.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111344298-A
priorityDate 2007-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007027344-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466778582
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466817873
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466817871

Total number of triples: 24.